Copyright
©The Author(s) 2023.
World J Gastroenterol. Apr 21, 2023; 29(15): 2322-2335
Published online Apr 21, 2023. doi: 10.3748/wjg.v29.i15.2322
Published online Apr 21, 2023. doi: 10.3748/wjg.v29.i15.2322
Part | Variable | B | SE | Wald | P | OR (95%Cl) |
Part I | RDW (%) | 0.777 | 0.173 | 20.141 | < 0.001 | 2.175 (1.549, 3.054) |
TBIL (μmol/L) | -0.086 | 0.051 | 2.810 | 0.094 | 0.918 (0.83, 1.015) | |
ALB (g/L) | -0.060 | 0.035 | 2.973 | 0.085 | 0.942 (0.879, 1.008) | |
ALT (IU/L) | 0.122 | 0.067 | 3.350 | 0.067 | 1.129 (0.991, 1.287) | |
AST (IU/L) | -0.108 | 0.060 | 3.178 | 0.075 | 0.898 (0.798, 1.011) | |
γ-GT (IU/L) | 0.004 | 0.011 | 0.117 | 0.733 | 1.004 (0.982, 1.026) | |
WBC count (× 109/L) | 0.026 | 0.107 | 0.059 | 0.808 | 1.026 (0.832, 1.265) | |
Hemoglobin (g/L) | 0.012 | 0.010 | 1.294 | 0.255 | 1.012 (0.992, 1.032) | |
Platelet count (× 109/L) | -0.006 | 0.003 | 3.638 | 0.056 | 0.994 (0.988, 1.000) | |
INR | 0.418 | 0.290 | 2.074 | 0.150 | 1.519 (0.86, 2.683) | |
NT-proBNP (pg/mL) | 0.001 | 0.002 | 0.417 | 0.518 | 1.001 (0.997, 1.005) | |
eGFR (mL/min/1.73 m2) | -0.009 | 0.012 | 0.598 | 0.439 | 0.991 (0.967, 1.015) | |
Hyperlipidemia | -0.074 | 0.346 | 0.046 | 0.831 | 0.929 (0.471, 1.830) | |
Atrial fibrillation | -0.402 | 0.602 | 0.448 | 0.503 | 0.669 (0.206, 2.174) | |
Haematemesis | -0.730 | 0.711 | 1.054 | 0.305 | 0.482 (0.12, 1.942) | |
Edema | 0.105 | 1.196 | 0.008 | 0.930 | 1.111 (0.107, 11.580) | |
SBP | 1.623 | 2.242 | 0.524 | 0.469 | 5.07 (0.063, 410.934) | |
Hyponatremia | -1.682 | 0.934 | 3.243 | 0.072 | 0.186 (0.030, 1.16) | |
Hepatic encephalopathy | -0.161 | 0.804 | 0.040 | 0.842 | 0.852 (0.176, 4.119) | |
Jaundice | -1.044 | 1.264 | 0.683 | 0.409 | 0.352 (0.030, 4.188) | |
Refractory ascites | 0.256 | 1.498 | 0.029 | 0.864 | 1.292 (0.069, 24.324) | |
Part II | RDW (%) | 0.895 | 0.294 | 9.265 | 0.002 | 2.447 (1.375, 4.354) |
TBIL (μmol/L) | -0.028 | 0.083 | 0.116 | 0.733 | 0.972 (0.825, 1.145) | |
ALB (g/L) | -0.723 | 0.140 | 26.552 | < 0.001 | 0.485 (0.369, 0.639) | |
ALT (IU/L) | 0.337 | 0.087 | 15.167 | < 0.001 | 1.401 (1.182, 1.660) | |
AST (IU/L) | -0.390 | 0.087 | 19.883 | < 0.001 | 0.677 (0.571, 0.804) | |
γ-GT (IU/L) | 0.037 | 0.018 | 4.313 | 0.038 | 1.037 (1.002, 1.074) | |
WBC count (× 109/L) | 0.592 | 0.253 | 5.464 | 0.019 | 1.807 (1.100, 2.969) | |
Hemoglobin (g/L) | -0.057 | 0.026 | 4.929 | 0.026 | 0.944 (0.898, 0.993) | |
Platelet count (× 109/L) | -0.055 | 0.010 | 32.104 | < 0.001 | 0.947 (0.929, 0.965) | |
INR | 1.894 | 0.563 | 11.321 | 0.001 | 6.643 (2.205, 20.018) | |
NT-proBNP (pg/mL) | 0.008 | 0.003 | 8.203 | 0.004 | 1.008 (1.003, 1.014) | |
eGFR (mL/min/1.73 m2) | 0.062 | 0.027 | 5.365 | 0.021 | 1.064 (1.010, 1.121) | |
Hyperlipidemia | -1.173 | 0.658 | 3.174 | 0.075 | 0.309 (0.085, 1.125) | |
Atrial fibrillation | 0.365 | 1.006 | 0.132 | 0.717 | 1.441 (0.201, 10.345) | |
Haematemesis | 2.282 | 1.499 | 2.318 | 0.128 | 9.792 (0.519, 184.678) | |
Edema | 3.004 | 1.778 | 2.855 | 0.091 | 20.159 (0.618, 657.095) | |
SBP | 4.715 | 4.750 | 0.985 | 0.321 | 111.572 (0.010, 1231574.165) | |
Hyponatremia | -0.424 | 1.259 | 0.113 | 0.736 | 0.655 (0.055, 7.724) | |
Hepatic encephalopathy | -1.850 | 1.290 | 2.057 | 0.151 | 0.157 (0.013, 1.970) | |
Jaundice | 1.862 | 2.392 | 0.606 | 0.436 | 6.437 (0.059, 699.588) | |
Refractory ascites | -1.431 | 3.819 | 0.140 | 0.708 | 0.239 (0, 425.671) | |
Part III | RDW (%) | 1.582 | 0.341 | 21.541 | < 0.001 | 4.863 (2.493, 9.483) |
TBIL (μmol/L) | -0.080 | 0.090 | 0.787 | 0.375 | 0.923 (0.774, 1.101) | |
ALB (g/L) | -0.910 | 0.150 | 37.020 | < 0.001 | 0.402 (0.300, 0.539) | |
ALT (IU/L) | 0.350 | 0.087 | 16.273 | < 0.001 | 1.419 (1.197, 1.682) | |
AST (IU/L) | -0.410 | 0.088 | 21.725 | < 0.001 | 0.664 (0.559, 0.789) | |
γ-GT (IU/L) | 0.032 | 0.018 | 3.226 | 0.072 | 1.033 (0.997, 1.070) | |
WBC count (× 109/L) | 0.763 | 0.292 | 6.798 | 0.009 | 2.144 (1.208, 3.803) | |
Hemoglobin (g/L) | -0.070 | 0.029 | 5.697 | 0.017 | 0.932 (0.880, 0.988) | |
Platelet count (× 109/L) | -0.077 | 0.013 | 35.070 | < 0.001 | 0.926 (0.902, 0.950) | |
INR | 1.828 | 0.621 | 8.661 | 0.003 | 6.224 (1.842, 21.031) | |
NT-proBNP (pg/mL) | 0.008 | 0.003 | 7.937 | 0.005 | 1.008 (1.002, 1.014) | |
eGFR (mL/min/1.73 m2) | -0.005 | 0.033 | 0.018 | 0.892 | 0.995 (0.932, 1.063) | |
Hyperlipidemia | -0.404 | 0.764 | 0.280 | 0.597 | 0.667 (0.149, 2.986) | |
Atrial fibrillation | 0.417 | 1.132 | 0.135 | 0.713 | 1.517 (0.165, 13.954) | |
Haematemesis | 3.164 | 1.693 | 3.493 | 0.062 | 23.67 (0.857, 653.530) | |
Edema | 3.826 | 1.882 | 4.132 | 0.042 | 45.891 (1.147, 1836.043) | |
SBP | 5.570 | 4.815 | 1.339 | 0.247 | 262.503 (0.021, 3291299.144) | |
Hyponatremia | -0.376 | 1.364 | 0.076 | 0.783 | 0.687 (0.047, 9.940) | |
Hepatic encephalopathy | -1.949 | 1.468 | 1.763 | 0.184 | 0.142 (0.008, 2.530) | |
Jaundice | 0.527 | 2.529 | 0.043 | 0.835 | 1.694 (0.012, 240.821) | |
Refractory ascites | -0.538 | 3.896 | 0.019 | 0.890 | 0.584 (0, 1210.714) |
- Citation: Chen YL, Zhao ZW, Li SM, Guo YZ. Value of red blood cell distribution width in prediction of diastolic dysfunction in cirrhotic cardiomyopathy. World J Gastroenterol 2023; 29(15): 2322-2335
- URL: https://www.wjgnet.com/1007-9327/full/v29/i15/2322.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i15.2322